Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Stryker (SYK). But which of these two stocks offers value investors a better bang for ...

Stryker (NYSE: SYK) has outperformed the market over the past 10 years by 1.46% on an annualized basis producing an average annual return of 14.57%. Currently, Stryker has a market capitalization of ...

Stryker SYK is well-poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. An improvement in price also buoys optimism. Shares of this ...

If you are wondering whether Stryker at around $351 a share is still a smart buy, or if the best days are already priced in, you are not alone. This breakdown aims to unpack that question. The stock ...

Parnassus Investments, an investment management firm, released its “Parnassus Value Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund focuses on ...

Portage, Michigan-based Stryker Corporation (SYK) is a leading global medical technology company specializing in orthopaedics ...

Stryker Corporation stock is recommended as a Buy due to its steady earnings growth, margin improvements, and strategic acquisitions, with a one-year price target 12.66% higher. Recent financial ...

Stryker continues to generate solid growth, despite a challenging demand environment, with Mako, Pangea, and the Inari acquisition driving growth. Stryker's margins should trend higher as it scales ...

Stryker (NYSE: SYK), the medical devices powerhouse, has recently launched its Sync Badge—a hands-free, wearable communication device designed to enhance collaboration among healthcare teams. This new ...

Needham upgrades Stryker Corp to Buy, sets $392 target, citing new product launches and strong capital equipment backlog. Analyst expects Stryker's margin improvement and increased M&A activity to ...